Dual-Biofluid Metabolomic Profiling by MALDI-MS Enables Noninvasive Diagnosis and Prognosis of Central Nervous System Infections
Analytical Chemistry · 2026
DOI: 10.1021/acs.analchem.6c02708 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2026. Verfasst von Xiaochen Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Beijing National Laboratory for Molecular Sciences, Key Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry, Chinese Aca…. Hauptthemen laut MEDLINE: Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Metabolomics, Central Nervous System Infections. Die Arbeit nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China (NSFC), First-class Discipline Breakthrough Initiative of Hainan University.
Abstract (Originalsprache)
Central nervous system (CNS) infections represent a common but serious complication following neurosurgical procedures. However, the metabolic alterations induced by infection remain incompletely understood, and noninvasive monitoring strategies remain urgently needed. In this study, we conducted a systematic metabolomic analysis of two biofluids─cerebrospinal fluid (CSF) and urine─obtained from patients undergoing neurosurgical procedures, using matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS). Metabolomic analysis of CSF revealed significant metabolic reprogramming associated with CNS infections, primarily characterized by the dysregulation of energy metabolism, amino acid metabolism, lipid and membrane-related pathways. Interestingly, similar pathway perturbations were also observed in the urinary metabolome. We further observed a significant comprehensive correlation between the urinary and CSF metabolomes. Then, machine learning models were successfully constructed based on urinary metabolomic features for noninvasive disease diagnosis and prognostic evaluation. Both the diagnostic and prognostic models achieved satisfactory classification performance, with area under the receiver operating characteristic curve values greater than 0.9. This work presents a novel, rapid, and noninvasive strategy for the detection and clinical management of CNS infections, which may facilitate timely and accurate clinical intervention and ultimately improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Beijing National Laboratory for Molecular Sciences, Key Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry, Chinese Academy of Sciences;Beijing100190, China.
- University of Chinese Academy of Sciences, Beijing100049, China.
- Department of Neurosurgery for Cerebrospinal Fluid Diseases, Aviation General Hospital, Beijing100012, China.
- Sanya Central Hospital the Third People's Hospital of Hainan Province, Hainan University, Haikou, Hainan570228, China.
ORCID-Profile: Jing Han, Zongxiu Nie
Förderung
- National Natural Science Foundation of China (NSFC)
- First-class Discipline Breakthrough Initiative of Hainan University
Zitieren
APA
Lu, X., Han, J., Chen, H., Wang, S., Cong, W., Qi, G., & Nie, Z. (2026). Dual-Biofluid Metabolomic Profiling by MALDI-MS Enables Noninvasive Diagnosis and Prognosis of Central Nervous System Infections. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.6c02708
Vancouver
Lu X, Han J, Chen H, Wang S, Cong W, Qi G, et al. Dual-Biofluid Metabolomic Profiling by MALDI-MS Enables Noninvasive Diagnosis and Prognosis of Central Nervous System Infections. Analytical Chemistry. 2026. doi:10.1021/acs.analchem.6c02708
BibTeX
@article{Lu2026,
author = {Lu, Xiaochen and Han, Jing and Chen, Hongwei and Wang, Shengjie and Cong, Wenkai and Qi, Guanghong and Nie, Zongxiu},
title = {Dual-Biofluid Metabolomic Profiling by MALDI-MS Enables Noninvasive Diagnosis and Prognosis of Central Nervous System Infections},
journal = {Analytical Chemistry},
year = {2026},
doi = {10.1021/acs.analchem.6c02708}
}
EUVIMED